CSL’s 9-year plasma contract worth $3.4bn
SYDNEY: Australian biotech giant CSL will receive $3.4 billion over nine years from the federal
SYDNEY: Australian biotech giant CSL will receive $3.4 billion over nine years from the federal
FEATURED
One in three grandparents regularly babysit their grandkids
Carers increasingly socially isolated and highly distressed claims reveals
Development to be model for extremely affordable senior housing
Developers shake up build-to-rent holdings as sector fires
Drones now fly blood samples in skies for first time
Affordable towns not set to face influx of over-65s
INNOVATION
